Q1 2025 · 13F-HR
StepStone Group LPholdings as filed
Filed 2025-05-14 · accession 0000950123-25-005172
$97.4M
Reported value
16
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 60938K304 | — | MONEYLION, INC. | $52.7M | 54.1% | 622,931 | Common | SOLE |
| 90364P105 | PATH | UIPATH, INC. | $13.3M | 13.6% | 1,286,527 | Common | SOLE |
| 26142V105 | DKNG | DRAFTKINGS INC | $7.1M | 7.32% | 214,536 | Common | SHARED |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS, INC. | $6.9M | 7.07% | 761,277 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC. | $3.6M | 3.65% | 525,247 | Common | SOLE |
| 781154109 | RBRK | RUBRIK, INC. | $3.3M | 3.37% | 53,838 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS, INC. | $2.6M | 2.72% | 422,085 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $2.1M | 2.17% | 491,938 | Common | SOLE |
| 48553T106 | BZ | KANZHUN LIMITED | $2.0M | 2.08% | 105,645 | Common | SOLE |
| 43157M102 | — | HILLEVAX, INC. | $1.2M | 1.23% | 826,569 | Common | SOLE |
| 91854V206 | — | VACASA, INC. | $792,264 | 0.81% | 147,261 | Common | SOLE |
| 358054104 | FRSH | FRESHWORKS INC. | $600,888 | 0.62% | 42,586 | Common | SHARED |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLDINGS, INC. | $513,517 | 0.53% | 380,383 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $435,051 | 0.45% | 7,497 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS, INC. | $263,433 | 0.27% | 462,163 | Common | SOLE |
| 03213A104 | AMPL | AMPLITUDE | $22,775 | 0.02% | 2,235 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.